OVARIAN CANCER

Although ovarian cancer chemotherapy drug developed considerable progress has been made, but patients with ovarian cancer and the overall survival rate has not improved markedly. Philadelphia's Fox Chase Hospital Dr. Bernard of ovarian cancer screening, treatment and prevention of, and possible future trends.

Tags: age, cancer, carboplatin, carcinoma, cause, cell, cells, chemotherapy, clinical, cox, drug, drugs, early, eat, exploration, grams, growth, incidence, method, ovarian, paclitaxel, patients, positive, preventive, protein, rate, reduce, response, risk, screening, surgical, survival, taxol, therapy, treatment, tumor

1. The only benign ovarian tumor treatment is surgical excision. Cyst less than 5 ~ 6 cm in diameter, observed 3 to 6 months, continue to increase, or tumor is smaller than 5 cm in diameter, but for solid tumors, surgical resection should be.

2. Children, pregnant young patients with no more side to side or ovariectomy Annex resection. As for the bilateral benign ovarian tumors, ovarian tumors to be stripped of, as far as possible to retain some ovarian tissue to maintain menstruation and reproductive functions. Right after menopause, and bilateral ovarian tumors while uterine bilateral resection of the annex, was advocated in recent years should be retained normal ovarian tissue, and maintain normal physiological functions of women.

Tags: annex, benign, cancer, children, cyst, eat, exploration, ovarian, patients, resection, surgical, treatment, tumor, tumors, uterine, women

Laparoscopic surgery for ovarian cancer patients with secondary exploration (2 exploration) is a safe and accurate method, this low rate of surgical complications occurred, and two exploration negative rate and relapse rate and the results are pretty open two exploration. This is the Stanford University School of Medicine obstetrics and gynecology physicians Amreen, the Sloan-Kettering Cancer Center from July 1993 to December 1998, 150 cases of laparoscopic ovarian cancer surgery two exploration data were retrospectively analyzed the results. (Markov MD 2001, 80: 44) 150 cases of ovarian cancer two exploration laparoscopic surgery patients, with an average age of 53 years. The majority (87%) patients in the first stage of ovarian cancer surgery for stage III or stage IV, II or for the remaining phases. 82 cases (54%) patients in the initial surgery was satisfied with the cytoreductive surgery. All patients completed the initial chemotherapy, the level of CA125, and imaging showed complete remission clinical. 69 patients (46%) 2 Exploration negative, the positive rate was 54%. Laparotomy to the proportion was 12% (18/150 cases), 3 patients due to the abdominal and intestinal damage, one of the patients had bladder injury; Other patients because it wants to be secondary cytoreductive surgery and to open surgery, patients only 1 because of extensive adhesion to give up laparoscopic abdominal surgery. Therefore, the overall complication rate was 2.7%.

Tags: abdominal, age, cancer, cases, cause, chemotherapy, clinical, exploration, method, ovarian, patients, positive, rate, second, surgery, surgical, therapy

Ovarian cancer is very common, all ages can ill, but 20 to 50 years old the most. Since early ovarian cancer patients have few symptoms, so early diagnosis difficult, attendance at the 70% already advanced, little access to early treatment, five-year survival rate always hovering in the 20 ~ 30%, is the most serious threat to women's lives malignant one.

One, classification

Tags: abdominal, administration, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, cases, cause, cell, cells, chemotherapy, children, cisplatin, clinical, cyst, cystic, cysts, diagnosis, drug, drugs, early, eat, ert, examination, exploration, gene, group, growth, gynecological, history, incidence, increased, injection, intraperitoneal, irradiation, lymph, malignant, mass, metastasis, metastatic, method, node, oppression, ovarian, pain, patients, pelvic, poor, positive, powder, protein, radiation, radiotherapy, rate, reduce, resection, residual, response, second, study, surface, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, uterine, women

Whitney physicians that cisplatin / paclitaxel chemotherapy in the treatment of ovarian cancer treatment should become the new standard.

Carboplatin / taxol treatment programs, and the current phase III epithelial ovarian tumors standard chemotherapy - cisplatin / paclitaxel, the same as its efficacy, toxicity small. Experts believe that the program should become a new standard treatment programs.

Combination of paclitaxel and cisplatin, paclitaxel must be sustained 24-hour infusion, and Taxol and carboplatin compatibility, 3-hour infusion of paclitaxel can, thus reducing low toxic side effects to a large extent.

Tags: age, cancer, carboplatin, cases, cause, chemotherapy, cisplatin, clinical, drug, early, eat, ert, exploration, grams, group, infusion, injection, method, ovarian, paclitaxel, pain, patients, prognosis, rate, residual, risk, second, study, surgery, survival, taxol, therapy, toxicity, treatment, tumor, tumors